D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 107 Citations 41,970 445 World Ranking 2801 National Ranking 4

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Disease

Robin Wood mainly investigates Acquired immunodeficiency syndrome, Internal medicine, Immunology, Tuberculosis and Sida. His Acquired immunodeficiency syndrome research incorporates elements of Cohort study, Mortality rate, Demography, Viral load and Risk factor. His Mortality rate study combines topics from a wide range of disciplines, such as Pediatrics, Gerontology and Public health.

His Internal medicine research includes elements of Meningitis, Surgery and Gastroenterology. His Immunology research is multidisciplinary, relying on both Pharmacotherapy, Immune reconstitution inflammatory syndrome, Epidemiology and Intensive care medicine. Robin Wood focuses mostly in the field of Tuberculosis, narrowing it down to matters related to Incidence and, in some cases, Opportunistic infection.

His most cited work include:

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study (2421 citations)
  • Initiation of antiretroviral therapy in early asymptomatic HIV infection (1575 citations)
  • Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. (986 citations)

What are the main themes of his work throughout his whole career to date?

Robin Wood mostly deals with Tuberculosis, Acquired immunodeficiency syndrome, Immunology, Internal medicine and Antiretroviral therapy. His biological study spans a wide range of topics, including Incidence, Pediatrics and Disease. His research integrates issues of Developing country, Demography, Cohort study and Cohort in his study of Acquired immunodeficiency syndrome.

Robin Wood has researched Immunology in several fields, including Pharmacotherapy, Epidemiology, Risk factor and Intensive care medicine. The various areas that Robin Wood examines in his Internal medicine study include Gastroenterology, Surgery and Viral load. Robin Wood combines subjects such as Regimen, Reverse-transcriptase inhibitor and Hazard ratio with his study of Viral load.

He most often published in these fields:

  • Tuberculosis (40.16%)
  • Acquired immunodeficiency syndrome (31.41%)
  • Immunology (31.41%)

What were the highlights of his more recent work (between 2015-2021)?

  • Tuberculosis (40.16%)
  • Internal medicine (28.23%)
  • Mycobacterium tuberculosis (9.74%)

In recent papers he was focusing on the following fields of study:

Tuberculosis, Internal medicine, Mycobacterium tuberculosis, Demography and Viral load are his primary areas of study. His Tuberculosis research includes themes of Incidence, Pediatrics, Disease and Environmental health. Robin Wood studied Incidence and Cohort study that intersect with Epidemiology.

His Internal medicine research is multidisciplinary, incorporating elements of Zidovudine and Antiretroviral therapy. His Viral load study is related to the wider topic of Immunology. His research in Acquired immunodeficiency syndrome tackles topics such as Confidence interval which are related to areas like Cart.

Between 2015 and 2021, his most popular works were:

  • Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study (74 citations)
  • Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study (68 citations)
  • Drivers of Tuberculosis Transmission. (56 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Disease

Robin Wood mainly focuses on Tuberculosis, Mycobacterium tuberculosis, Internal medicine, Acquired immunodeficiency syndrome and Young adult. The concepts of his Tuberculosis study are interwoven with issues in Anemia and Hepcidin. His research in Mycobacterium tuberculosis intersects with topics in Transmission, Sputum and Disease, Cause of death.

The study incorporates disciplines such as Resistance, Pharmacology and Antiretroviral therapy in addition to Internal medicine. Robin Wood has included themes like Epidemiology, Cohort study, Hazard ratio, Pediatrics and Triage in his Acquired immunodeficiency syndrome study. His Young adult study incorporates themes from Dolutegravir, Demography and Incidence.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka.
PLOS ONE (2015)

3959 Citations

Initiation of antiretroviral therapy in early asymptomatic HIV infection

Sean Emery;Shweta Sharma;Gerd Fätkenheuer;Josep M. Llibre.
The New England Journal of Medicine (2015)

2255 Citations

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

P Braitstein;Mwg Brinkhof;F Dabis;M Schechter.
The Lancet (2006)

1285 Citations

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

F van Leth;P Phanuphak;K Ruxrungtham;E Baraldi.
The Lancet (2004)

953 Citations

Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa.

Stephen D Lawn;Anthony D Harries;Xavier Anglaret;Landon Myer.
AIDS (2008)

813 Citations

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.

Motasim Badri;Douglas Wilson;Robin Wood.
The Lancet (2002)

752 Citations

Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study

Sean Emery;Jacqueline A. Neuhaus;Andrew N. Phillips;Abdel Babiker.
The Journal of Infectious Diseases (2008)

548 Citations

Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort.

Stephen D Lawn;Motasim Badri;Robin Wood.
AIDS (2005)

472 Citations

Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design.

Stephen D Lawn;Landon Myer;Catherine Orrell;Linda-Gail Bekker.
AIDS (2005)

466 Citations

Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.

Stephen D Lawn;Landon Myer;Linda-Gail Bekker;Robin Wood.
AIDS (2006)

463 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Robin Wood

Graeme Meintjes

Graeme Meintjes

University of Cape Town

Publications: 189

Nathan Ford

Nathan Ford

World Health Organization

Publications: 154

Robert J. Wilkinson

Robert J. Wilkinson

The Francis Crick Institute

Publications: 142

Matthias Egger

Matthias Egger

University of Bern

Publications: 140

Anthony D. Harries

Anthony D. Harries

International Union Against Tuberculosis and Lung Disease

Publications: 136

Gavin J. Churchyard

Gavin J. Churchyard

Aurum Institute

Publications: 128

Stephen D. Lawn

Stephen D. Lawn

University of London

Publications: 119

Kenneth A. Freedberg

Kenneth A. Freedberg

Harvard University

Publications: 115

Elizabeth L. Corbett

Elizabeth L. Corbett

University of London

Publications: 113

Robert Colebunders

Robert Colebunders

University of Antwerp

Publications: 103

Kenneth H. Mayer

Kenneth H. Mayer

Fenway Health

Publications: 95

David R. Bangsberg

David R. Bangsberg

Oregon Health & Science University

Publications: 95

Elena Losina

Elena Losina

Brigham and Women's Hospital

Publications: 95

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 94

François Dabis

François Dabis

University of Bordeaux

Publications: 93

Linda-Gail Bekker

Linda-Gail Bekker

University of Cape Town

Publications: 93

Something went wrong. Please try again later.